Key Points
- ASP Isotopes CFO Heather Kiessling sold 21,830 shares for $47,807.70, reducing her holdings by 1.43% to 1,504,422 shares. The sale was reportedly made to cover tax withholding obligations related to vested equity awards.
- ASPI opened at $2.09, near its 12-month low of $1.89 and well below its 50-day and 200-day moving averages. The company’s latest quarterly results included an EPS loss of $0.28, missing estimates, although revenue of $5.12 million exceeded expectations.
- Analyst sentiment remains mixed, with an overall “Hold” rating and a consensus price target of $13.00; institutional investors own 16.8% of the company.
ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) CFO Heather Kiessling sold 21,830 shares of ASP Isotopes stock in a transaction on Friday, October 16th. The shares were sold at an average price of $2.19, for a total value of $47,807.70. Following the completion of the transaction, the chief financial officer owned 1,504,422 shares in the company, valued at $3,294,684.18. The trade was a 1.43% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
ASP Isotopes Stock Performance
ASPI stock opened at $2.09 on Friday. The stock has a 50-day moving average price of $3.22 and a two-hundred day moving average price of $4.66. ASP Isotopes Inc. has a 12-month low of $1.89 and a 12-month high of $11.22. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.87 and a quick ratio of 3.85.
ASP Isotopes (NASDAQ:ASPI - Get Free Report) last announced its quarterly earnings results on Friday, August 14th. The company reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.17) by ($0.11). The firm had revenue of $5.12 million for the quarter, compared to analyst estimates of $4.47 million. ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%.
Hedge Funds Weigh In On ASP Isotopes
Hedge funds have recently made changes to their positions in the business. The Manufacturers Life Insurance Company lifted its holdings in shares of ASP Isotopes by 8.8% during the 1st quarter. The Manufacturers Life Insurance Company now owns 30,503 shares of the company's stock valued at $135,000 after acquiring an additional 2,470 shares in the last quarter. Sanctuary Advisors LLC boosted its position in ASP Isotopes by 22.2% during the 1st quarter. Sanctuary Advisors LLC now owns 24,615 shares of the company's stock worth $109,000 after purchasing an additional 4,465 shares during the period. Royal Bank of Canada boosted its position in ASP Isotopes by 18.4% during the 1st quarter. Royal Bank of Canada now owns 37,954 shares of the company's stock worth $167,000 after purchasing an additional 5,906 shares during the period. State of Wyoming purchased a new stake in ASP Isotopes during the 1st quarter worth $29,000. Finally, Allworth Financial LP acquired a new stake in ASP Isotopes in the 2nd quarter valued at $51,000. Hedge funds and other institutional investors own 16.80% of the company's stock.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on the company. Weiss Ratings reiterated a "sell (d-)" rating on shares of ASP Isotopes in a report on Monday, September 21st. Wall Street Zen upgraded shares of ASP Isotopes from a "strong sell" rating to a "sell" rating in a report on Saturday, August 22nd. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat, ASP Isotopes currently has an average rating of "Hold" and a consensus price target of $13.00.
Check Out Our Latest Stock Analysis on ASPI
ASP Isotopes Company Profile
(
Get Free Report)
ASP Isotopes Inc is a materials and technology company developing isotope-enrichment processes for use in the medical, semiconductor and nuclear-energy industries. Its primary technology is the Aerodynamic Separation Process, a proprietary method designed to separate isotopes based on differences in molecular mass and aerodynamic behavior.
The company is pursuing the production of enriched isotopes, including materials intended for applications such as semiconductor manufacturing, medical diagnostics and treatment, advanced nuclear fuels, and other industrial and scientific uses.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
